Enzo Biochem Stock Analysis

ENZ -  USA Stock  

USD 2.91  0.01  0.34%

The current slide in stock price could raise concerns from investors as the firm it trading at a share price of 2.91 on 610,100 in volume. The company executives have failed to build on market volatilities in May. However, diversifying your overall positions with Enzo Biochem may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.89. The current volatility is consistent with the ongoing market swings in May 2021 as well as with Enzo Biochem unsystematic, company-specific events.
Continue to Investing Opportunities.

Search Stock Analysis 

The Enzo Biochem stock analysis report makes it easy to digest most publicly released information about Enzo Biochem and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Enzo Biochem stock analysis module also helps to analyze the Enzo Biochem price relationship with some important fundamental indicators such as market cap and management efficiency.

Enzo Biochem Stock Analysis Notes

About 61.0% of the company shares are held by institutions such as insurance companies. The book value of Enzo Biochem was currently reported as 1.28. The company recorded a loss per share of 0.23. Enzo Biochem had not issued any dividends in recent years. The entity had 105:100 split on the 21st of October 2004. Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York. Enzo Biochem operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 408 people. To learn more about Enzo Biochem call Elazar Rabbani at 212 583-0100 or check out www.enzo.com.

Enzo Biochem Quarterly Cost of Revenue

16.75 MillionShare

Enzo Biochem Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Enzo Biochem's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Enzo Biochem or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Enzo Biochem generates negative expected return over the last 90 days
Enzo Biochem has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 96.55 M. Reported Net Loss for the year was (10.58 M) with profit before taxes, overhead, and interest of 23.77 M.
Enzo Biochem has about 44.54 M in cash with (11.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92.
Roughly 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.marketscreener.com: Enzo Biochem Reports Third Quarter Fiscal 2021 Results - Marketscreener.com

Enzo Biochem SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Enzo Biochem prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Enzo Biochem investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Enzo Biochem specific information freely available to individual and institutional investors to make a timely investment decision.
14th of June 2021
Other Events
11th of June 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
5th of May 2021
Unclassified Corporate Event
19th of March 2021
Other Events
17th of March 2021
Unclassified Corporate Event
16th of March 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
26th of February 2021
Unclassified Corporate Event
11th of February 2021
Unclassified Corporate Event

Enzo Biochem Thematic Classifications

In addition to having Enzo Biochem stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

Enzo Biochem Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Enzo Biochem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enzo Biochem backward and forwards among themselves. Enzo Biochem's institutional investor refers to the entity that pools money to purchase Enzo Biochem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Harbert Fund Advisors IncCommon Shares5.2 M17.8 M
Blackrock IncCommon Shares3.9 M13.4 M
Renaissance Technologies LlcCommon Shares3.3 M11.5 M
Roumell Asset Management LlcCommon Shares2.7 M9.4 M
Evermore Global Advisors LlcCommon Shares2.6 MM
Vanguard Group IncCommon Shares2.4 M8.2 M
Dimensional Fund Advisors LpCommon Shares1.6 M5.6 M
Group One Trading LpPut Options1.1 M3.8 M
Note, although Enzo Biochem's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enzo Biochem Market Capitalization

The company currently falls under 'Small-Cap' category with total capitalization of 139.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzo Biochem's market, we take the total number of its shares issued and multiply it by Enzo Biochem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Enzo Biochem Profitablity

Enzo Biochem's profitability indicators refer to fundamental financial ratios that showcase Enzo Biochem's ability to generate income relative to its revenue or operating costs. If, let's say, Enzo Biochem is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Enzo Biochem's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Enzo Biochem's profitability requires more research than a typical breakdown of Enzo Biochem's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (10.96) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (12.38) %, which entails that for every $100 of revenue, it lost -0.12.
Last ReportedProjected for 2021
Return on Investment(34.06) (34.95) 
Return on Average Assets(0.28) (0.28) 
Return on Average Equity(0.49) (0.50) 
Return on Invested Capital(0.57) (0.59) 
Return on Sales(0.44) (0.45) 

Management Efficiency

The entity has Return on Asset of (6.53) % which means that on every $100 spent on asset, it lost $6.53. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (15.96) %, meaning that it generated no profit with money invested by stockholders. Enzo Biochem management efficiency ratios could be used to measure how well enzo biochem manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -34.95 in 2021. Return on Average Equity is likely to drop to -0.5 in 2021. Enzo Biochem Goodwill and Intangible Assets are fairly stable at the moment as compared to the past year. Enzo Biochem reported Goodwill and Intangible Assets of 7.19 Million in 2020. Revenue to Assets is likely to rise to 1.05 in 2021, whereas Total Assets are likely to drop slightly above 122.1 M in 2021.
Last ReportedProjected for 2021
Book Value per Share 1.10  1.24 
Enterprise Value over EBIT(3.45) (3.72) 
Enterprise Value over EBITDA(3.78) (3.88) 
Price to Book Value 2.24  2.87 
Tangible Assets Book Value per Share 2.52  2.31 
Enterprise Value99.1 M149.7 M
Tangible Asset Value120.2 M106.4 M

Technical Drivers

As of the 19th of June, Enzo Biochem shows the mean deviation of 2.43, and Coefficient Of Variation of (647.09). Enzo Biochem technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Enzo Biochem, which can be compared to its rivals. Please confirm Enzo Biochem jensen alpha and semi variance to decide if Enzo Biochem is priced favorably, providing market reflects its regular price of 2.91 per share. Please also check Enzo Biochem total risk alpha, which is currently at (0.66) to verify the company can sustain itself at a future point.

Enzo Biochem Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Enzo Biochem more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Enzo Biochem Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Enzo Biochem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Enzo Biochem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Enzo Biochem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Enzo Biochem Predictive Daily Indicators

Enzo Biochem intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Enzo Biochem stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Enzo Biochem Forecast Models

Enzo Biochem time-series forecasting models is one of many Enzo Biochem's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enzo Biochem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Enzo Biochem Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enzo Biochem stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enzo Biochem shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Enzo Biochem. By using and applying Enzo Biochem Stock analysis, traders can create a robust methodology for identifying Enzo Biochem entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(35.95) (36.89) 
EBITDA Margin(0.40) (0.41) 
Gross Margin 0.28  0.32 
Profit Margin(0.43) (0.44) 
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York. Enzo Biochem operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 408 people.

Current Enzo Biochem Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enzo Biochem analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enzo Biochem analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
8.0Strong Buy1Odds
Enzo Biochem current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Enzo Biochem analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Enzo Biochem stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Enzo Biochem, talking to its executives and customers, or listening to Enzo Biochem conference calls.
Enzo Biochem Analyst Advice Details

Enzo Biochem Stock Analysis Indicators

Enzo Biochem stock analysis indicators help investors evaluate how Enzo Biochem stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enzo Biochem shares will generate the highest return on investment. By understating and applying Enzo Biochem stock analysis, traders can identify Enzo Biochem position entry and exit signals to maximize returns.
Quick Ratio1.89
Fifty Two Week Low1.8000
Revenue Growth62.30%
Shares Short Prior Month1.82M
Average Daily Volume Last 10 Day1.03M
Average Daily Volume In Three Month1.24M
Shares Percent Shares Out3.10%
Gross Margins41.42%
Short Percent Of Float3.81%
Forward Price Earnings-7.44
Float Shares35.73M
Fifty Two Week High4.8500
Enterprise Value To Ebitda-13.70
Fifty Day Average3.0735
Two Hundred Day Average2.9999
Enterprise Value To Revenue1.32
Continue to Investing Opportunities. Note that the Enzo Biochem information on this page should be used as a complementary analysis to other Enzo Biochem's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Enzo Biochem Stock analysis

When running Enzo Biochem price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo Biochem that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine Enzo Biochem value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.